Solid-State Characterization of Different Crystalline Forms of Sitagliptin

Sitagliptin is an inhibitor of the enzyme dipeptidyl peptidase-4, used for the treatment of type 2 diabetes mellitus. The crystal structure of active pharmaceutical solids determines their physical and chemical properties. The polymorphism, solvates and hydrates can influence the free energy, thermo...

Descripción completa

Detalles Bibliográficos
Autores principales: Stofella, Nayana C. F., Veiga, Andressa, Oliveira, Laiane J., Montin, Elisa F., Andreazza, Itamar F., Carvalho Filho, Marco A. S., Bernardi, Larissa S., Oliveira, Paulo R., Murakami, Fábio S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696402/
https://www.ncbi.nlm.nih.gov/pubmed/31344887
http://dx.doi.org/10.3390/ma12152351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696402/
https://www.ncbi.nlm.nih.gov/pubmed/31344887
http://dx.doi.org/10.3390/ma12152351

Ejemplares similares